|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 413/14 | |
| A61K 31/5355 | |||
| A61P 3/04 | |||
| A61P 3/10 | |||
| A61P 9/12 | |||
| A61P 25/28 | |||
| A61K 45/06 |
| (11) | Patento numeris | 3023423 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15197854.1 |
| Europos patento paraiškos padavimo data | 2012-08-23 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-05-25 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-05-31 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 201161527172 P | 2011-08-25 | US | |
| 201261665395 P | 2012-06-28 | US |
| (72) |
LUEOEND, Rainer Martin, CH
MACHAUER, Rainer, CH
RUEEGER, Heinrich, CH
VEENSTRA, Siem Jacob, CH
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | 2 -AMINO-4 - (PYRIDIN- 2 -YL) - 5, 6 -DIHYDRO-4H- 1, 3 -OXAZINE DERIVATIVES AND THEIR USE AS BACE-1 AND/OR BACE - 2 INHIBITORS |
| 2 -AMINO-4 - (PYRIDIN- 2 -YL) - 5, 6 -DIHYDRO-4H- 1, 3 -OXAZINE DERIVATIVES AND THEIR USE AS BACE-1 AND/OR BACE - 2 INHIBITORS |